English | Español
Press release submission | Jul 12, 2019

EIP PHARMA, INC.: Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies
Press release submission | Jul 2, 2019

BIOGEN, INC.: Announces New Data Further Establishing SPINRAZA® (nusinersen) as a Foundation of Care in Spinal Muscular Atrophy for a Broad Range of Patients
Press release submission | Jul 1, 2019

EXPERIMENTAL BIOLOGY AND MEDICINE: A New Target for the Treatment of Idiopathic Pulmonary Fibrosis
Press release submission | Jun 28, 2019

AJ VACCINES: Will Contribute to Global Polio Eradication With its Innovative Vaccine Picovax
Press release submission | Jun 27, 2019

CHILDREN'S NATIONAL HEALTH SYSTEM: Children's National study identifies potential pupillary biomarker for pediatric bowel and bladder dysfunction (BBD) that could improve diagnosis and intervention
Press release submission | Jun 21, 2019

FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH: New research provides insight into immunity of lupus patients
Press release submission | Jun 20, 2019

SUMMIT MEDICAL GROUP: CityMD and Summit Medical Group Announce Plans to Merge to Deliver an Unparalleled Patient Care Experience
Press release submission | Jun 14, 2019

JOHNSON & JOHNSON: Janssen reports top-line Phase 3 results for TREMFYA® (guselkumab) in adults with active psoriatic arthritis

Trending
Patient Daily | Oct 23, 2025

Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues
Patient Daily | Oct 23, 2025

Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'
+ Pharmaceuticals
Patient Daily | Oct 23, 2025

Empower seeks dismissal of Eli Lilly suit in Texas federal court
+ Pharmaceuticals
Patient Daily | Oct 29, 2025

Paragon Health Institute senior fellow: 340B program 'needs real reform'